Spoken Alpha
LQDA
Liquidia Corp
Overview
Liquidia Corp is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $6.77B market cap.
LQDA beat consensus EPS by 0.3% in Q1 FY2026, reported May 6, 2026.
20 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-117 Q&A exchanges
- Q4 FY2025Earnings2026-03-059 Q&A exchanges
- Q3 FY2025Earnings2025-11-0312 Q&A exchanges
- Q2 FY2025Earnings2025-08-1210 Q&A exchanges
- Q1 FY2025Earnings2025-05-1011 Q&A exchanges
- Q4 FY2024Earnings2025-03-199 Q&A exchanges
- Q3 FY2024Earnings2024-11-1311 Q&A exchanges
- Q2 FY2024Earnings2024-08-0810 Q&A exchanges
- Q1 FY2024Earnings2024-05-148 Q&A exchanges
- Q4 FY2023Earnings2024-03-1311 Q&A exchanges
- Q3 FY2023Earnings2023-11-077 Q&A exchanges
- Q2 FY2023Earnings2023-08-1010 Q&A exchanges
- Q1 FY2023Earnings2023-05-069 Q&A exchanges
- Q4 FY2022Earnings2023-03-168 Q&A exchanges
- Q3 FY2022Earnings2022-11-0812 Q&A exchanges
- Q2 FY2022Earnings2022-08-1110 Q&A exchanges
- Q1 FY2022Earnings2022-05-123 Q&A exchanges
- Q4 FY2021Earnings2022-03-178 Q&A exchanges
- Q2 FY2021Earnings2021-08-107 Q&A exchanges
- Q1 FY2021Earnings2021-05-134 Q&A exchanges
History
Earnings history
- Q1 FY20262026-05-06EPS$0.52 vs $0.41+28.4%Rev$132.9M vs ——EODHD
- Q4 FY20252026-03-11EPS$0.15 vs $0.19-22.0%Rev$92.0M vs ——EODHD
- Q3 FY20252025-11-02EPS$-0.04 vs $-0.41+90.2%Rev$54.3M vs ——EODHD
- Q2 FY20252025-08-11EPS$-0.49 vs $-0.42-16.7%Rev$8.8M vs ——EODHD
- Q1 FY20252025-05-11EPS$-0.45 vs $-0.42-7.1%Rev$3.1M vs ——EODHD
- Q4 FY20242025-03-10EPS$-0.45 vs $-0.40-13.9%Rev$2.9M vs ——EODHD
- Q3 FY20242024-11-04EPS$-0.39 vs $-0.37-4.8%Rev$4.4M vs ——EODHD
- Q2 FY20242024-08-06EPS$-0.37 vs $-0.34-8.8%Rev$3.7M vs ——EODHD
- Q1 FY20242024-05-12EPS$-0.54 vs $-0.32-68.8%Rev$3.0M vs ——EODHD
- Q4 FY20232024-03-12EPS$-0.42 vs $-0.24-75.0%Rev$4.5M vs ——EODHD
- Q3 FY20232023-11-06EPS$-0.24 vs $-0.21-14.3%Rev$3.7M vs ——EODHD
- Q2 FY20232023-08-09EPS$-0.36 vs $-0.16-100.0%Rev$4.8M vs ——EODHD
- Q1 FY20232023-05-03EPS$-0.18 vs $-0.16-12.5%Rev$4.5M vs ——EODHD
- Q4 FY20222023-03-15EPS$-0.09 vs $-0.15+40.0%Rev$5.4M vs ——EODHD
- Q3 FY20222022-11-07EPS$-0.14 vs $-0.17+17.6%Rev$3.2M vs ——EODHD
- Q2 FY20222022-08-10EPS$-0.15 vs $-0.23+34.8%Rev$3.9M vs ——EODHD
- Q1 FY20222022-05-11EPS$-0.30 vs $-0.20-50.0%Rev$3.5M vs ——EODHD
- Q4 FY20212022-03-16EPS$-0.23 vs $-0.11-100.0%Rev$3.2M vs ——EODHD
- Q3 FY20212021-11-02EPS$-0.14 vs $-0.12-16.7%Rev$3.2M vs ——EODHD
- Q2 FY20212021-08-09EPS$-0.13 vs $-0.15+13.3%Rev$3.4M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q1 FY2026 | 2026-05-06 | $0.52 | $0.41 | +28.4% | $132.9M | — | — | EODHD |
| Q4 FY2025 | 2026-03-11 | $0.15 | $0.19 | -22.0% | $92.0M | — | — | EODHD |
| Q3 FY2025 | 2025-11-02 | $-0.04 | $-0.41 | +90.2% | $54.3M | — | — | EODHD |
| Q2 FY2025 | 2025-08-11 | $-0.49 | $-0.42 | -16.7% | $8.8M | — | — | EODHD |
| Q1 FY2025 | 2025-05-11 | $-0.45 | $-0.42 | -7.1% | $3.1M | — | — | EODHD |
| Q4 FY2024 | 2025-03-10 | $-0.45 | $-0.40 | -13.9% | $2.9M | — | — | EODHD |
| Q3 FY2024 | 2024-11-04 | $-0.39 | $-0.37 | -4.8% | $4.4M | — | — | EODHD |
| Q2 FY2024 | 2024-08-06 | $-0.37 | $-0.34 | -8.8% | $3.7M | — | — | EODHD |
| Q1 FY2024 | 2024-05-12 | $-0.54 | $-0.32 | -68.8% | $3.0M | — | — | EODHD |
| Q4 FY2023 | 2024-03-12 | $-0.42 | $-0.24 | -75.0% | $4.5M | — | — | EODHD |
| Q3 FY2023 | 2023-11-06 | $-0.24 | $-0.21 | -14.3% | $3.7M | — | — | EODHD |
| Q2 FY2023 | 2023-08-09 | $-0.36 | $-0.16 | -100.0% | $4.8M | — | — | EODHD |
| Q1 FY2023 | 2023-05-03 | $-0.18 | $-0.16 | -12.5% | $4.5M | — | — | EODHD |
| Q4 FY2022 | 2023-03-15 | $-0.09 | $-0.15 | +40.0% | $5.4M | — | — | EODHD |
| Q3 FY2022 | 2022-11-07 | $-0.14 | $-0.17 | +17.6% | $3.2M | — | — | EODHD |
| Q2 FY2022 | 2022-08-10 | $-0.15 | $-0.23 | +34.8% | $3.9M | — | — | EODHD |
| Q1 FY2022 | 2022-05-11 | $-0.30 | $-0.20 | -50.0% | $3.5M | — | — | EODHD |
| Q4 FY2021 | 2022-03-16 | $-0.23 | $-0.11 | -100.0% | $3.2M | — | — | EODHD |
| Q3 FY2021 | 2021-11-02 | $-0.14 | $-0.12 | -16.7% | $3.2M | — | — | EODHD |
| Q2 FY2021 | 2021-08-09 | $-0.13 | $-0.15 | +13.3% | $3.4M | — | — | EODHD |
Source: EODHD. LQDA reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks LQDA's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 50% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $4.64 | $3.79 | +22.5% | +2.3% | +5.2% |
| Q4 FY2026 | $4.18 | $3.71 | +12.7% | -4.1% | -4.5% |
| Q3 FY2026 | $4.26 | $3.65 | +16.8% | +2.0% | -0.1% |
| Q2 FY2026 | $3.96 | $3.65 | +8.6% | +2.1% | +4.4% |
| Q1 FY2025 | $4.34 | $3.81 | +13.9% | 0.0% | +1.8% |
| Q4 FY2025 | $4.31 | $3.67 | +17.5% | -3.3% | -2.1% |
| Q3 FY2025 | $4.07 | $3.69 | +10.2% | -3.8% | -4.2% |
| Q2 FY2025 | $4.33 | $3.92 | +10.4% | +1.7% | +1.6% |
| Q1 FY2024 | $4.24 | $3.86 | +9.8% | +4.1% | +4.6% |
| Q4 FY2024 | $4.16 | $3.83 | +8.5% | -5.2% | -4.1% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Roger JeffsCEO5 mo18 callsCurrentSample
CEO since 2026 • 2/2 beats (100%) • last guidance cut Q1 FY2026
- Michael KasetaCFO5 mo20 callsCurrentSample
CFO since 2026 • 1/2 beats (50%) • last guidance cut Q1 FY2026
- Sanjeev KhindriChief Development Officer5 mono recorded callsCurrentSample
OTHER_C_SUITE since 2026 • 1/2 beats (50%) • last guidance cut Q2 FY2026
- Jason AdairChief Business Officer5 mo20 callsCurrentSample
OTHER_C_SUITE since 2026 • 1/2 beats (50%) • guidance suspended Q1 FY2026
- Scott MoomawChief Commercial Officer5 mo9 callsCurrentSample
OTHER_C_SUITE since 2026 • 1/2 beats (50%) • last guidance cut Q1 FY2026
- Dana BoyleChief Accounting Officer5 mono recorded callsCurrentSample
OTHER_C_SUITE since 2026 • 2/2 beats (100%) • last guidance raise Q1 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for LQDA.
$ curl https://api.spokenalpha.com/v1/companies/LQDAFAQ
Frequently asked about LQDA
Where can I find Liquidia Corp's (LQDA) earnings call transcripts?
Spoken Alpha indexes LQDA's earnings call transcripts at https://spokenalpha.com/companies/LQDA. Each call links to attributed speakers and parsed analyst Q&A. Liquidia Corp's own investor relations page is at https://www.liquidia.com/investors/overview.
When was Liquidia Corp's most recent earnings call?
Liquidia Corp (LQDA) held its most recent earnings call on 2026-05-11, covering fiscal Q1 2026.
What sector is LQDA in?
Liquidia Corp (LQDA) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).